Dr. Clay Siegall l is an expert in cancer therapy; the medical doctor is also the co-founder and the Chief Executive Officer of Seattle Genetics. The healthcare firm deals with targeted therapy drugs for certain types of diseases which have not seen considerable humanity enhancements for an extended period. He went to the University of Maryland where he pursued Bachelors of Science in Zoology and later graduated with Ph.D. in Genetics from George Washington University. Since the foundation of the medical organization, Dr. Clay has been at the forefront of leading the company to be a leader in the target therapy sector. He led Seattle Genetics to the development of the first Anti-body Conjugate Drug which was approved by FDA.
Being a go-getter and devoted to what he does in the medical industry, Dr. Clay Siegall has contributed significantly to the expansion of Seattle from a start-up to the most extensive research organization which is playing a primary role in the medical sector in improving and studying on cancer treatment. Dr. Clay is committed to take the company to greater heights and build its bright future. With authority, the firm is expected to make a difference in the pharmaceutical industry due to their increased number of drugs in the industry as well as the ones in the channel. It is Dr. Siegall’s believe that chemotherapy is an old cancer treatment and should not be used with the advancement of technology and study.
Recently the cancer expert conducted an interview and was asked what inspired him to establish Seattle Genetics. Dr. Clay said that from an early age he had a passion for medicine, a reason to overcome disease and the power of technology, as well as to retain health to those who had no hope of living. He wanted to change the way cancer was being treated as from experience cancer had severe side effects on patients. Asked how they make money the Chief Executive Officer and Co-founder of Seattle said that they have their drugs and sell them to make money. Clay believes it is through hard work and having the passion to work has led to their success an all their achievements as individuals as well as an organization.